A Core Outcome Set for Trials in CKD: Report of the Standardized Outcomes in Nephrology-Chronic Kidney Disease (SONG-CKD) Stakeholder Workshops

By sjmartinez • May 24, 2025

Matus Gonzalez A, Cazzolli R, Madero M, Evangelidis N, Howell M, Sautenet B, Bernier-Jean A, Cho Y, Sanabria LC, Craig JC, de Boer IH, Fung S, Gallego D, Guha C, Shen JI, Levey AS, Levin A, Lorca E, Cabrera S, Mellado H, Molina S, Atilano X, Sandino L, Arancibia M, Sepulveda A, Urra M, Bravo MLA, Manera K, Recabarren J, Okpechi IG, Rossignol P, Scholes-Robertson N, Sola L, Teixeira-Pinto A, Usherwood T, Viecelli AK, Wheeler DC, Widders K, Jaure A; SONG-CKD Stakeholder Workshop Investigators. A Core Outcome Set for Trials in CKD: Report of the Standardized Outcomes in Nephrology-Chronic Kidney Disease (SONG-CKD) Stakeholder Workshops. Am J Kidney Dis. 2025 Jun;85(6):745-753. doi: 10.1053/j.ajkd.2024.10.013. Epub 2025 Jan 23. PMID: 39855535.

Tags: Cardiology/Epi, Chronic kidney disease, Core outcome set, Outcomes, patient-centered care, Publications, trials

Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression

Chen J, Zhou Q, Su L, Ni L. Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression. Ren Fail. 2025 Dec;47(1):2506812. doi: 10.1080/0886022X.2025.2506812. Epub[...]

Established and Emerging Fluorine-18-Labeled Cardiac PET Radiotracers

Packard RRS, Pelletier-Galarneau M, Malhotra S, Dorbala S, Chen W, Dilsizian V. Established and Emerging Fluorine-18-Labeled Cardiac PET Radiotracers. JACC Cardiovasc Imaging. 2025 May 13:S1936-878X(25)00173-1.[...]

Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective

Wilkinson MJ, Bijlani P, Davidson MH, Duell PB, Horan M, Malloy MJ, Newfield RS, Pradeep P, Shah PK, Stock EO, Warden BA, Ito MK. Real-World[...]